Animas Targets Profitability In 2005 Despite Insulin Pump Production Issues
This article was originally published in The Gray Sheet
Executive Summary
Animas expects to clear up supplier issues hindering production of its IR1200 insulin pump by October, as increased demand tips the firm toward profitability in 2005, President & CEO Katherine Crothall says
You may also be interested in...
Insulin Pump Market Will Expand With MEMS Technology – Animas
Animas aims to introduce a next-generation insulin micro-pump to the U.S. in 2007, having acquired rights to Debiotech's micro-electromechanical systems (MEMS) technology
Insulin Pump Market Will Expand With MEMS Technology – Animas
Animas aims to introduce a next-generation insulin micro-pump to the U.S. in 2007, having acquired rights to Debiotech's micro-electromechanical systems (MEMS) technology
Animas IPO: Insulin Pump Maker Offers Up To $69 Mil. In Stock
Proceeds from Animas Corp.'s initial public offering will support sales and marketing of the IR 1200 third-generation insulin pump and evaluation of continuous glucose sensor technology licensed from Thomas Jefferson University, the manufacturer notes